{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:56:51Z","timestamp":1761512211766},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,3,8]],"date-time":"2006-03-08T00:00:00Z","timestamp":1141776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s00115-006-2060-8","type":"journal-article","created":{"date-parts":[[2006,3,7]],"date-time":"2006-03-07T17:33:31Z","timestamp":1141752811000},"page":"912-922","source":"Crossref","is-referenced-by-count":3,"title":["Lamotrigin bei Frauen"],"prefix":"10.1007","volume":"78","author":[{"given":"B.","family":"Schmitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,3,8]]},"reference":[{"key":"2060_CR1","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1212\/WNL.63.10_suppl_4.S9","volume":"63","author":"Gilliam","year":"2004","unstructured":"Gilliam F, Carter J, Vahle V (2004) Tolerability of antiseizure medications: implications for health outcomes. Neurology 63(10\u00a0Suppl\u00a04):S9\u2013S12","journal-title":"Neurology"},{"key":"2060_CR2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archneur.61.7.1017","volume":"61","author":"Ortinski","year":"2004","unstructured":"Ortinski P, Meador KJ (2004) Neuronal mechanisms of conscious awareness. Arch Neurol 61:1017\u20131020","journal-title":"Arch Neurol"},{"key":"2060_CR3","unstructured":"GlaxoSmithKline (2005) Lamotrigine Pregnancy Registry, Interim report M\u00e4rz 2005. Data on file"},{"key":"2060_CR4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","volume":"77","author":"Morrow","year":"2006","unstructured":"Morrow JI, Russell A, Gutherie E et al. (2006) Malformation risks of anti-epileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77:193\u2013198","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2060_CR5","doi-asserted-by":"crossref","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (1998) Empfehlungen zur Planung und Durchf\u00fchrung von Anwendungsbeobachtungen. http:\/\/www.bfarm.de\/de\/Arzneimittel\/zul\/bekanntm\/index.php?more=awbver1.php . Download am 4.2.2005","DOI":"10.1007\/978-3-662-38283-7_2"},{"key":"2060_CR6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","volume":"22","author":"Commission","year":"1981","unstructured":"Commission on Classification and Terminology of the International League Against Epilepsy (1981) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22:489\u2013501","journal-title":"Epilepsia"},{"key":"2060_CR7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","volume":"30","author":"Commission","year":"1989","unstructured":"Commission on Classification and Terminology of the International League Against Epilepsy (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389\u2013399","journal-title":"Epilepsia"},{"key":"2060_CR8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.54.4.973","volume":"54","author":"Devinsky","year":"2000","unstructured":"Devinsky O, Vuong A, Hammer A et al. (2000) Stable weight during lamotrigine therapy: a review of 32 studies. Neurology 54:973\u2013975","journal-title":"Neurology"},{"key":"2060_CR9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1212\/WNL.56.2.172","volume":"56","author":"Biton","year":"2001","unstructured":"Biton V, Mirza W, Montouris G et al. (2001) Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology 56:172\u2013177","journal-title":"Neurology"},{"key":"2060_CR10","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.4088\/JCP.v65n1219b","volume":"65","author":"Nielsen","year":"2004","unstructured":"Nielsen JN, Licht RW, Fogh K (2004) Two cases of acneiform eruption associated with lamotrigine. J Clin Psychiatry 65:1720\u20131722","journal-title":"J Clin Psychiatry"},{"key":"2060_CR11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archneur.1986.00520040029014","volume":"43","author":"Herzog","year":"1986","unstructured":"Herzog AG, Seibel M, Schomer DL et al. (1986) Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol 43:341\u2013346","journal-title":"Arch Neurol"},{"key":"2060_CR12","first-page":"3078","volume":"83","author":"Knochenhauser","year":"1998","unstructured":"Knochenhauser ES, Key TJ, Kashar-Miller M et al. (1998) Prevalence of polycystic ovarian syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078\u20133082","journal-title":"J Clin Endocrinol Metab"},{"key":"2060_CR13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/seiz.1999.0342","volume":"8","author":"Taub","year":"1999","unstructured":"Taub\u00f8ll E, Isoj\u00e4rvi JIT, Flinstad-Harbo H et al. (1999) Long-term valproate treatment induces changes in ovarian morphology and serum sex steroid hormone levels in female Wistar rats. Seizure 8:490\u2013493","journal-title":"Seizure"},{"key":"2060_CR14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM199311043291904","volume":"329","author":"Isoj","year":"1993","unstructured":"Isoj\u00e4rvi JIT, Laatikainen TJ, Knip M et al. (1993) Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 329:1383\u20131388","journal-title":"N Engl J Med"},{"key":"2060_CR15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ana.410390506","volume":"39","author":"Isoj","year":"1996","unstructured":"Isoj\u00e4rvi JIT, Laatikainen TJ, Knip M et al. (1996) Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 39:579\u2013584","journal-title":"Ann Neurol"},{"key":"2060_CR16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.410430406","volume":"43","author":"Isoj","year":"1998","unstructured":"Isoj\u00e4rvi JI, R\u00e4ttya J, Myllyl\u00e4 VV et al. (1998) Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 43:446\u2013451","journal-title":"Ann Neurol"},{"key":"2060_CR17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.10391","volume":"52","author":"Morrell","year":"2002","unstructured":"Morrell MJ, Giudice L, Flynn KL et al. (2002) Predictors of ovulatory failure in women with epilepsy. Ann Neurol 52:704\u2013711","journal-title":"Ann Neurol"},{"key":"2060_CR18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0940-2993(01)80014-2","volume":"52","author":"R","year":"2001","unstructured":"R\u00f8ste LS, Taub\u00f8ll E, Berner A et al. (2001) Valproate, but not lamotrigine, induces ovarian morphological changes in Wistar rats. Exp Toxicol Pathol 52:545\u2013552","journal-title":"Exp Toxicol Pathol"},{"key":"2060_CR19","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1046\/j.1528-1157.2001.0420081002.x","volume":"42","author":"Stephen","year":"2001","unstructured":"Stephen LJ, Kwan P, Shapiro D et al. (2001) Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy. Epilepsia 42:1002\u20131006","journal-title":"Epilepsia"},{"key":"2060_CR20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0920-1211(03)00085-8","volume":"54","author":"Morrell","year":"2003","unstructured":"Morrell MJ, Isoj\u00e4rvi J, Taylor AE et al. (2003) Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy. Epilepsy Res 54:189\u2013199","journal-title":"Epilepsy Res"},{"key":"2060_CR21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00002018-199818040-00004","volume":"18","author":"Messenheimer","year":"1998","unstructured":"Messenheimer J, Mullens L, Giorgi L et al. (1998) Safety review of adult clinical trial experience with lamotrigine. Drug Saf 18:281\u2013296","journal-title":"Drug Saf"},{"key":"2060_CR22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/ebeh.2000.0143","volume":"2","author":"Edwards","year":"2001","unstructured":"Edwards KR, Sackellares JC, Vuong A et al. (2001) Lamotrigine monotherapy improves depressive symptoms in epilepsy: a double-blind comparison with valproate. Epilepsy Behav 2:28\u201336","journal-title":"Epilepsy Behav"},{"key":"2060_CR23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1525-5050(02)00528-0","volume":"3","author":"Kalogjera-Sackellares","year":"2002","unstructured":"Kalogjera-Sackellares D, Sackellares JC (2002) Improvement in depression associated with partial epilepsy in patients treated with lamotrigine. Epilepsy Behav 3:510\u2013516","journal-title":"Epilepsy Behav"},{"key":"2060_CR24","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.yebeh.2003.11.008","volume":"5","author":"Ortinski","year":"2004","unstructured":"Ortinski P, Meador KJ (2004) Cognitive side effects of antiepileptic drugs. Epilepsy Behav 5(Suppl\u00a01):S60\u2013S65","journal-title":"Epilepsy Behav"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-006-2060-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-006-2060-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-006-2060-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T05:00:49Z","timestamp":1558587649000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-006-2060-8"}},"subtitle":["Eine Anwendungsbeobachtung"],"short-title":[],"issued":{"date-parts":[[2006,3,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["2060"],"URL":"https:\/\/doi.org\/10.1007\/s00115-006-2060-8","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,8]]}}}